[KongchangAI]
Partially Verified65% confidenceFactTime unknown

氯雷他定为第二代抗组胺药,相比第一代(如扑尔敏)嗜睡副作用显著降低,适合需要日间保持清醒的过敏患者

3
Sources
65%
Confidence
Long-term
Relevance
-
First Seen

Sources

Related Entities

Related Claims

Cite This Claim

Stable URI
https://kongchang.com/claim/644840
API
curl https://kongchang.com/api/v1/knowledge/claims/644840
MCP
get_claim(id=644840)